Trial ID or NCT#

NCT03533582

Status

recruiting iconRECRUITING

Purpose

This partially randomized phase II/III trial studies how well, in combination with surgery, cisplatin and combination chemotherapy works in treating children and young adults with hepatoblastoma or hepatocellular carcinoma. Drugs used in chemotherapy, such as cisplatin, doxorubicin, fluorouracil, vincristine sulfate, carboplatin, etoposide, irinotecan, sorafenib, gemcitabine and oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving combination chemotherapy may kill more tumor cells than one type of chemotherapy alone.

Official Title

Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)

Eligibility Criteria

Ages Eligible for Study: Younger than 30 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Jay Michael S. Balagtas
Sheri Spunt

Contact us to find out if this trial is right for you.

CONTACT

Richard Fu
(650) 497-8815